NVIVQ InVivo Therapeutics Holdings Corp.Stock Price & Overview
$0.37
Charts
Quant Ranking
NVIVQ Analysis
NVIVQ News
Latest Headlines
People Also Follow
Similar to NVIVQ
ETFs Holding NVIVQ
NVIVQ Company Profile
InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
NVIVQ Revenue
NVIVQ Earnings Per Share
Earnings Revisions
Valuation
Profitability
Momentum
Capital Structure
Dividends
NVIVQ Ownership
NVIVQ Peers
Risk
Technicals
Investor Presentations
NVIVQ SEC Filings
NVIVQ Income Statement
NVIVQ Balance Sheet
NVIVQ Cash Flow Statement
NVIVQ Long Term Solvency
Discover More
You may be interested in: